Sfoglia per AUTORE
SENSI E
Collezione AO Cuneo

  

Items : 3

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Mar;109:175-182. doi: 10.1016/j.ejca.2018.12.028. Epub 2019 Feb 5.

2019
AO Cuneo

Fontanini G; Lonardi S; Sensi E; Tonini G; Schirripa M; Granetto C; Delfanti S; Di Donato S; Casagrande M; Gemma D; Borelli B; Allegrini G; Murgioni S; Antoniotti C; Dell'Aquila E; Masi G; Salvatore L; Aprile G; Bergamo F; Marmorino F; Cremolini C; Boni L; Falcone A;

Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Jul;29(7):1528-1534. doi: 10.1093/annonc/mdy140. Epub 2018 Apr 20.

2018
AO Cuneo
AOU Città della Salute di Torino

Zagonel V; Sensi E; Masi G; Granetto C; Allegrini G; Buonadonna A; Marmorino F; Tonini G; Zaniboni A; Loupakis F; Racca P; Ronzoni M; Moretto R; Tomasello G; Bergamo F; Cortesi E; Lonardi S; Antoniotti C; Cremolini C; Fontanini G; Boni L; Falcone A;

Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Mar;73:74-84. doi: 10.1016/j.ejca.2016.10.028. Epub 2016 Dec 13.

2017
AO Cuneo

Pellegrinelli A; Sensi E; Pilati P; Cillo U; Urbani L; Granetto C; Ferrari L; Allegrini G; Tonini G; Tomasello G; Zucchelli G; Marmorino F; Pietrantonio F; Moretto R R; Masi G; Bergamo F; Aprile G; Loupakis F; Cremolini C; Casagrande M; Milione M; Fontanini G; Falcone A;